A detailed history of Stifel Financial Corp transactions in Certara, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 29,794 shares of CERT stock, worth $335,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,794
Previous 30,353 1.84%
Holding current value
$335,778
Previous $420,000 17.14%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.46 - $16.58 $5,847 - $9,268
-559 Reduced 1.84%
29,794 $348,000
Q2 2024

Aug 13, 2024

BUY
$13.36 - $18.94 $22,044 - $31,251
1,650 Added 5.75%
30,353 $420,000
Q1 2024

May 13, 2024

BUY
$15.65 - $19.45 $449,201 - $558,273
28,703 New
28,703 $513,000
Q2 2023

Aug 14, 2023

SELL
$16.89 - $24.64 $2.1 Million - $3.06 Million
-124,285 Reduced 88.78%
15,700 $285,000
Q1 2023

May 12, 2023

BUY
$15.9 - $24.72 $128,503 - $199,787
8,082 Added 6.13%
139,985 $3.38 Million
Q4 2022

Feb 13, 2023

SELL
$10.7 - $17.84 $146,504 - $244,265
-13,692 Reduced 9.4%
131,903 $2.12 Million
Q3 2022

Nov 14, 2022

SELL
$12.84 - $24.13 $56,470 - $106,123
-4,398 Reduced 2.93%
145,595 $1.93 Million
Q2 2022

Aug 15, 2022

BUY
$16.75 - $22.54 $28,022 - $37,709
1,673 Added 1.13%
149,993 $3.22 Million
Q1 2022

May 13, 2022

SELL
$17.89 - $28.73 $8,318 - $13,359
-465 Reduced 0.31%
148,320 $3.19 Million
Q4 2021

Feb 14, 2022

BUY
$26.1 - $45.21 $3.64 Million - $6.3 Million
139,280 Added 1465.33%
148,785 $4.23 Million
Q3 2021

Nov 15, 2021

BUY
$24.46 - $38.41 $14,186 - $22,277
580 Added 6.5%
9,505 $315,000
Q2 2021

Aug 13, 2021

BUY
$24.79 - $33.31 $22,707 - $30,511
916 Added 11.44%
8,925 $253,000
Q1 2021

May 14, 2021

BUY
$25.58 - $39.0 $204,870 - $312,351
8,009 New
8,009 $219,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.8B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.